These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25820982)
21. The selective dopamine D Nesbit MO; Chai A; Axerio-Cilies P; Phillips AG; Wang YT; Held K Neuropharmacology; 2022 Apr; 207():108967. PubMed ID: 35077763 [TBL] [Abstract][Full Text] [Related]
22. The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials. Pezze MA; Marshall HJ; Cassaday HJ Learn Motiv; 2016 Aug; 55():53-64. PubMed ID: 27524835 [TBL] [Abstract][Full Text] [Related]
23. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. Gurden H; Takita M; Jay TM J Neurosci; 2000 Nov; 20(22):RC106. PubMed ID: 11069975 [TBL] [Abstract][Full Text] [Related]
24. Role of medial prefrontal cortex dopamine in age differences in response to amphetamine in rats: locomotor activity after intra-mPFC injections of dopaminergic ligands. Mathews IZ; McCormick CM Dev Neurobiol; 2012 Nov; 72(11):1415-21. PubMed ID: 22081646 [TBL] [Abstract][Full Text] [Related]
25. Microinfusion of the D1 receptor antagonist, SCH23390 into the IL but not the BLA impairs consolidation of extinction of auditory fear conditioning. Hikind N; Maroun M Neurobiol Learn Mem; 2008 Jul; 90(1):217-22. PubMed ID: 18442937 [TBL] [Abstract][Full Text] [Related]
26. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine. De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849 [TBL] [Abstract][Full Text] [Related]
27. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. Sorg BA; Li N; Wu WR J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of dopamine D1 and D2 receptor antagonists on conditioned orienting behavior in the rat. Chang YH; Liao RM Chin J Physiol; 2003 Dec; 46(4):159-68. PubMed ID: 15074836 [TBL] [Abstract][Full Text] [Related]
29. Opposing roles of prelimbic and infralimbic dopamine in conditioned cue and place preference. Hayen A; Meese-Tamuri S; Gates A; Ito R Psychopharmacology (Berl); 2014 Jun; 231(12):2483-92. PubMed ID: 24429871 [TBL] [Abstract][Full Text] [Related]
32. Dopamine D1 versus D4 receptors differentially modulate the encoding of salient versus nonsalient emotional information in the medial prefrontal cortex. Lauzon NM; Bishop SF; Laviolette SR J Neurosci; 2009 Apr; 29(15):4836-45. PubMed ID: 19369552 [TBL] [Abstract][Full Text] [Related]
34. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats. Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047 [TBL] [Abstract][Full Text] [Related]
35. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Pan WH; Yang SY; Lin SK Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740 [TBL] [Abstract][Full Text] [Related]
36. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Ramos M; Goñi-Allo B; Aguirre N Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107 [TBL] [Abstract][Full Text] [Related]